ARMISTICE CAPITAL, LLC purchased 1.0% of their position (455K shares) of AVALO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $452.8K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 1/14/2022ACC: 0000899243-22-002025
Director10% Owner
Since Jun 2018
+455K
Net shares
Net buyer
$452.8K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
455K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+57.30K
Price / share
$1.04
Trade value
$59.78K
% of position
0.1%
1/12/2022
45.65M→45.70M
Common Stock
Indirect
Shares
+312.70K
Price / share
$1.00
Trade value
$314.01K
% of position
0.7%
1/13/2022
45.70M→46.02M
Common Stock
Indirect
Shares
+85K
Price / share
$0.93
Trade value
$78.97K
% of position
0.2%
1/14/2022
46.02M→46.10M
Total
Net shares
+455K
Net value
$452.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/12/2022 | P · Purchase | +57.30K | $1.04 | $59.78K | 0.1% | 45.65M | 45.70M |
| Common Stock Indirect | 1/13/2022 | P · Purchase | +312.70K | $1.00 | $314.01K | 0.7% | 45.70M | 46.02M |
| Common Stock Indirect | 1/14/2022 | P · Purchase | +85K | $0.93 | $78.97K | 0.2% | 46.02M | 46.10M |
| Total | +455K | $452.77K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned412.44K
Total
412.44K direct412.44K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 412.44K | Direct |
| Total | 412.44K | 412.44K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported